StockData
GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Glucose Health, Inc.

Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026

Market cap
$1.82M
P/E (TTM)
–
Dividend yield
–

Glucose Health, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2017

Profitability, TTM

Gross margin
65.4%
Operating margin
-36.8%
Net margin
-96.5%
Return on equity, FY2016
92.9%

Financial strength

Current ratio
0.06
Debt to equity
–
Debt to assets
–
Cash to current liabilities
3.7%

Valuation

P/E ratio
–
Price to sales
20.71
Price to book
–
Dividend yield
–